Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas

Maria Letizia Motti, Carmela De Marco, Daniela Califano, Silvia De Gisi, Donatella Malanga, Giancarlo Troncone, Angela Persico, Simona Losito, Fernanda Fabiani, Massimo Santoro, Gennaro Chiappetta, Alfredo Fusco, Giuseppe Viglietto

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS/BRAF/MAP kinase-dependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumors - as detected by immunostaining for p-ERK - presented high p27 degradative activity and low levels of p27 protein (n = 30; p <0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.

Original languageEnglish
Pages (from-to)2817-2825
Number of pages9
JournalCell Cycle
Volume6
Issue number22
Publication statusPublished - Nov 15 2007

Fingerprint

Thyroid Neoplasms
Phosphotransferases
Proto-Oncogene Proteins B-raf
MAP Kinase Signaling System
Cells
S-Phase Kinase-Associated Proteins
Proteins
Antisense Oligonucleotides
Mitogen-Activated Protein Kinase Kinases
Cell proliferation
Oncogenes
Tumors
Thyroid Gland
Cell Proliferation
Growth
Neoplasms

Keywords

  • MAP kinase
  • Oncogene
  • p27
  • SKP2
  • Thyroid cancer

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Cite this

Motti, M. L., De Marco, C., Califano, D., De Gisi, S., Malanga, D., Troncone, G., ... Viglietto, G. (2007). Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas. Cell Cycle, 6(22), 2817-2825.

Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas. / Motti, Maria Letizia; De Marco, Carmela; Califano, Daniela; De Gisi, Silvia; Malanga, Donatella; Troncone, Giancarlo; Persico, Angela; Losito, Simona; Fabiani, Fernanda; Santoro, Massimo; Chiappetta, Gennaro; Fusco, Alfredo; Viglietto, Giuseppe.

In: Cell Cycle, Vol. 6, No. 22, 15.11.2007, p. 2817-2825.

Research output: Contribution to journalArticle

Motti, ML, De Marco, C, Califano, D, De Gisi, S, Malanga, D, Troncone, G, Persico, A, Losito, S, Fabiani, F, Santoro, M, Chiappetta, G, Fusco, A & Viglietto, G 2007, 'Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas', Cell Cycle, vol. 6, no. 22, pp. 2817-2825.
Motti ML, De Marco C, Califano D, De Gisi S, Malanga D, Troncone G et al. Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas. Cell Cycle. 2007 Nov 15;6(22):2817-2825.
Motti, Maria Letizia ; De Marco, Carmela ; Califano, Daniela ; De Gisi, Silvia ; Malanga, Donatella ; Troncone, Giancarlo ; Persico, Angela ; Losito, Simona ; Fabiani, Fernanda ; Santoro, Massimo ; Chiappetta, Gennaro ; Fusco, Alfredo ; Viglietto, Giuseppe. / Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas. In: Cell Cycle. 2007 ; Vol. 6, No. 22. pp. 2817-2825.
@article{eab5f92a3f9545daa3f5208c733b3929,
title = "Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas",
abstract = "In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS/BRAF/MAP kinase-dependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumors - as detected by immunostaining for p-ERK - presented high p27 degradative activity and low levels of p27 protein (n = 30; p <0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.",
keywords = "MAP kinase, Oncogene, p27, SKP2, Thyroid cancer",
author = "Motti, {Maria Letizia} and {De Marco}, Carmela and Daniela Califano and {De Gisi}, Silvia and Donatella Malanga and Giancarlo Troncone and Angela Persico and Simona Losito and Fernanda Fabiani and Massimo Santoro and Gennaro Chiappetta and Alfredo Fusco and Giuseppe Viglietto",
year = "2007",
month = "11",
day = "15",
language = "English",
volume = "6",
pages = "2817--2825",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "22",

}

TY - JOUR

T1 - Loss of p27 expression through RAS→BRAF→MAP kinase-dependent pathway in human thyroid carcinomas

AU - Motti, Maria Letizia

AU - De Marco, Carmela

AU - Califano, Daniela

AU - De Gisi, Silvia

AU - Malanga, Donatella

AU - Troncone, Giancarlo

AU - Persico, Angela

AU - Losito, Simona

AU - Fabiani, Fernanda

AU - Santoro, Massimo

AU - Chiappetta, Gennaro

AU - Fusco, Alfredo

AU - Viglietto, Giuseppe

PY - 2007/11/15

Y1 - 2007/11/15

N2 - In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS/BRAF/MAP kinase-dependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumors - as detected by immunostaining for p-ERK - presented high p27 degradative activity and low levels of p27 protein (n = 30; p <0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.

AB - In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS/BRAF/MAP kinase-dependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumors - as detected by immunostaining for p-ERK - presented high p27 degradative activity and low levels of p27 protein (n = 30; p <0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.

KW - MAP kinase

KW - Oncogene

KW - p27

KW - SKP2

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=37249061098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249061098&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 2817

EP - 2825

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 22

ER -